annual CFO:
$6.31B+$1.89B(+42.58%)Summary
- As of today (September 17, 2025), TAK annual cash flow from operations is $6.31 billion, with the most recent change of +$1.89 billion (+42.58%) on March 1, 2025.
- During the last 3 years, TAK annual CFO has fallen by -$2.77 billion (-30.53%).
- TAK annual CFO is now -30.53% below its all-time high of $9.09 billion, reached on March 31, 2022.
Performance
TAK Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
$1.41B+$196.39M(+16.17%)Summary
- As of today (September 17, 2025), TAK quarterly cash flow from operations is $1.41 billion, with the most recent change of +$196.39 million (+16.17%) on June 1, 2025.
- Over the past year, TAK quarterly CFO has increased by +$387.92 million (+37.93%).
- TAK quarterly CFO is now -61.35% below its all-time high of $3.65 billion, reached on March 31, 2021.
Performance
TAK quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$6.68B+$387.92M(+6.16%)Summary
- As of today (September 17, 2025), TAK TTM cash flow from operations is $6.68 billion, with the most recent change of +$387.92 million (+6.16%) on June 1, 2025.
- Over the past year, TAK TTM CFO has increased by +$1.79 billion (+36.44%).
- TAK TTM CFO is now -30.87% below its all-time high of $9.67 billion, reached on December 31, 2021.
Performance
TAK TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TAK Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.6% | +37.9% | +36.4% |
| 3 y3 years | -30.5% | +195.0% | -19.3% |
| 5 y5 years | +23.6% | +30.6% | +25.6% |
TAK Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.5% | +42.6% | -42.6% | +195.0% | -19.3% | +51.2% |
| 5 y | 5-year | -30.5% | +42.6% | -61.4% | +195.0% | -30.9% | +51.2% |
| alltime | all time | -30.5% | +2755.3% | -61.4% | +218.1% | -30.9% | +5735.9% |
TAK Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.41B(+16.2%) | $6.68B(+6.2%) |
| Mar 2025 | $6.31B(+42.6%) | $1.21B(-49.2%) | $6.30B(-9.7%) |
| Dec 2024 | - | $2.39B(+43.1%) | $6.97B(+29.7%) |
| Sep 2024 | - | $1.67B(+63.3%) | $5.37B(+9.7%) |
| Jun 2024 | - | $1.02B(-45.9%) | $4.90B(+10.8%) |
| Mar 2024 | $4.43B(-31.6%) | $1.89B(+139.0%) | $4.42B(-5.3%) |
| Dec 2023 | - | $791.05M(-33.8%) | $4.67B(-26.3%) |
| Sep 2023 | - | $1.19B(+118.8%) | $6.33B(-3.6%) |
| Jun 2023 | - | $545.71M(-74.5%) | $6.57B(+1.0%) |
| Mar 2023 | $6.47B(-28.8%) | $2.14B(-13.0%) | $6.50B(-12.9%) |
| Dec 2022 | - | $2.46B(+71.9%) | $7.47B(-4.8%) |
| Sep 2022 | - | $1.43B(+198.9%) | $7.84B(-5.3%) |
| Jun 2022 | - | $478.13M(-84.6%) | $8.28B(-9.2%) |
| Mar 2022 | $9.09B(+6.5%) | $3.10B(+9.4%) | $9.12B(-5.7%) |
| Dec 2021 | - | $2.84B(+52.0%) | $9.67B(+12.9%) |
| Sep 2021 | - | $1.87B(+41.6%) | $8.57B(-3.2%) |
| Jun 2021 | - | $1.32B(-63.9%) | $8.85B(+2.8%) |
| Mar 2021 | $8.53B(+67.1%) | $3.65B(+110.4%) | $8.61B(+33.7%) |
| Dec 2020 | - | $1.73B(-19.3%) | $6.44B(+14.2%) |
| Sep 2020 | - | $2.15B(+98.9%) | $5.64B(+6.0%) |
| Jun 2020 | - | $1.08B(-27.0%) | $5.32B(+4.7%) |
| Mar 2020 | $5.11B(+87.2%) | $1.48B(+58.9%) | $5.08B(+13.8%) |
| Dec 2019 | - | $931.42M(-49.1%) | $4.47B(+2.7%) |
| Sep 2019 | - | $1.83B(+117.6%) | $4.35B(+35.6%) |
| Jun 2019 | - | $840.19M(-2.9%) | $3.20B(+17.4%) |
| Mar 2019 | $2.73B(-20.3%) | $865.07M(+6.5%) | $2.73B(-8.7%) |
| Dec 2018 | - | $811.98M(+18.3%) | $2.99B(+2.3%) |
| Sep 2018 | - | $686.60M(+87.9%) | $2.92B(-4.4%) |
| Jun 2018 | - | $365.47M(-67.5%) | $3.06B(-10.2%) |
| Mar 2018 | $3.42B(+42.6%) | $1.12B(+50.8%) | $3.40B(+1.7%) |
| Dec 2017 | - | $745.42M(-9.1%) | $3.35B(+17.6%) |
| Sep 2017 | - | $820.38M(+14.9%) | $2.84B(+9.0%) |
| Jun 2017 | - | $713.85M(-33.0%) | $2.61B(+9.9%) |
| Mar 2017 | $2.40B(+986.2%) | $1.07B(+336.5%) | $2.37B(+1973.4%) |
| Dec 2016 | - | $244.14M(-58.3%) | $114.53M(-77.4%) |
| Sep 2016 | - | $585.35M(+22.0%) | $507.81M(-5.0%) |
| Jun 2016 | - | $479.64M(-140.2%) | $534.50M(+141.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | $221.11M(-86.8%) | -$1.19B(-287.4%) | $221.51M(-86.5%) |
| Dec 2015 | - | $637.41M(+4.1%) | $1.64B(+2.0%) |
| Sep 2015 | - | $612.03M(+267.3%) | $1.61B(-5.1%) |
| Jun 2015 | - | $166.65M(-25.6%) | $1.69B(+2.0%) |
| Mar 2015 | $1.67B(+12.8%) | $223.93M(-63.0%) | $1.66B(+15.6%) |
| Dec 2014 | - | $605.09M(-13.3%) | $1.44B(+72.8%) |
| Sep 2014 | - | $698.16M(+425.0%) | $831.15M(+525.0%) |
| Jun 2014 | - | $132.99M(-90.6%) | $132.99M(-96.5%) |
| Mar 2014 | $1.48B(-63.1%) | - | - |
| Mar 2013 | $4.01B(-5.9%) | - | - |
| Mar 2012 | $4.26B(+11.6%) | - | - |
| Mar 2011 | $3.82B(-7.0%) | $1.42B(+94.1%) | $3.85B(+4.9%) |
| Dec 2010 | - | $732.62M(-42.4%) | $3.67B(-4.7%) |
| Sep 2010 | - | $1.27B(+197.9%) | $3.85B(+2.0%) |
| Jun 2010 | - | $426.69M(-65.6%) | $3.78B(-8.7%) |
| Mar 2010 | $4.10B(+26.5%) | $1.24B(+36.0%) | $4.13B(+42.9%) |
| Dec 2009 | - | $913.16M(-23.5%) | $2.89B(+46.1%) |
| Sep 2009 | - | $1.19B(+51.9%) | $1.98B(+151.9%) |
| Jun 2009 | - | $785.77M | $785.77M |
| Mar 2009 | $3.24B(+26.8%) | - | - |
| Mar 2008 | $2.56B(+43.0%) | - | - |
| Mar 2007 | $1.79B(-45.8%) | - | - |
| Mar 2006 | $3.30B(+20.0%) | - | - |
| Mar 2005 | $2.75B(-0.1%) | - | - |
| Mar 2004 | $2.75B(+27.4%) | - | - |
| Mar 2003 | $2.16B(+12.3%) | - | - |
| Mar 2002 | $1.93B(+0.1%) | - | - |
| Mar 2001 | $1.92B(+34.7%) | - | - |
| Mar 2000 | $1.43B(+72.8%) | - | - |
| Mar 1999 | $826.18M(-7.0%) | - | - |
| Mar 1998 | $888.04M(+6.6%) | - | - |
| Mar 1997 | $833.35M(-0.5%) | - | - |
| Mar 1996 | $837.55M(+3.7%) | - | - |
| Mar 1995 | $808.04M(-13.1%) | - | - |
| Mar 1994 | $929.36M(+83.1%) | - | - |
| Mar 1993 | $507.48M(-15.9%) | - | - |
| Mar 1992 | $603.37M(+67.4%) | - | - |
| Mar 1991 | $360.45M | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual cash flow from operations?
- What is the all time high annual CFO for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual CFO year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly cash flow from operations?
- What is the all time high quarterly CFO for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly CFO year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM cash flow from operations?
- What is the all time high TTM CFO for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM CFO year-on-year change?
What is Takeda Pharmaceutical Company Limited annual cash flow from operations?
The current annual CFO of TAK is $6.31B
What is the all time high annual CFO for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual cash flow from operations is $9.09B
What is Takeda Pharmaceutical Company Limited annual CFO year-on-year change?
Over the past year, TAK annual cash flow from operations has changed by +$1.89B (+42.58%)
What is Takeda Pharmaceutical Company Limited quarterly cash flow from operations?
The current quarterly CFO of TAK is $1.41B
What is the all time high quarterly CFO for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly cash flow from operations is $3.65B
What is Takeda Pharmaceutical Company Limited quarterly CFO year-on-year change?
Over the past year, TAK quarterly cash flow from operations has changed by +$387.92M (+37.93%)
What is Takeda Pharmaceutical Company Limited TTM cash flow from operations?
The current TTM CFO of TAK is $6.68B
What is the all time high TTM CFO for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM cash flow from operations is $9.67B
What is Takeda Pharmaceutical Company Limited TTM CFO year-on-year change?
Over the past year, TAK TTM cash flow from operations has changed by +$1.79B (+36.44%)